176 related articles for article (PubMed ID: 1151703)
21. Relationship of chemical structure to corneal penetration and influence of low-viscosity solution on ocular bioavailability.
Grass GM; Robinson JR
J Pharm Sci; 1984 Aug; 73(8):1021-7. PubMed ID: 6491903
[TBL] [Abstract][Full Text] [Related]
22. Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehicles.
Romanelli L; Valeri P; Morrone LA; Pimpinella G; Graziani G; Tita B
Life Sci; 1994; 54(13):877-85. PubMed ID: 8139376
[TBL] [Abstract][Full Text] [Related]
23. Pharmacokinetic prediction of the ocular absorption of an instilled drug with ophthalmic viscous vehicle.
Sasaki H; Yamamura K; Mukai T; Nishida K; Nakamura J; Nakashima M; Ichikawa M
Biol Pharm Bull; 2000 Nov; 23(11):1352-6. PubMed ID: 11085365
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic evidence for improved ophthalmic drug delivery by reduction of instilled volume.
Patton TF
J Pharm Sci; 1977 Jul; 66(7):1058-9. PubMed ID: 886449
[TBL] [Abstract][Full Text] [Related]
25. The instilled fluid dynamics and surface chemistry of polymers in the preocular tear film.
Benedetto DA; Shah DO; Kaufman HE
Invest Ophthalmol; 1975 Dec; 14(12):887-902. PubMed ID: 1104516
[TBL] [Abstract][Full Text] [Related]
26. Quantitative precorneal disposition of topically applied pilocarpine nitrate in rabbit eyes.
Patton TF; Robinson JR
J Pharm Sci; 1976 Sep; 65(9):1295-301. PubMed ID: 966141
[TBL] [Abstract][Full Text] [Related]
27. [Interactions between macromolecular adjuvants and drugs. Part 19: In vitro and in vivo testing of polyvinyl alcohol and other macromolecular adjuvants as vehicles for eyedrops (author's transl)].
Keipert S; Voigt R; Karst R; Nowak R
Pharmazie; 1979 Dec; 34(12):818-24. PubMed ID: 545352
[No Abstract] [Full Text] [Related]
28. Applications of poloxamers in ophthalmic pharmaceutical formulations: an overview.
Almeida H; Amaral MH; Lobão P; Sousa Lobo JM
Expert Opin Drug Deliv; 2013 Sep; 10(9):1223-37. PubMed ID: 23688342
[TBL] [Abstract][Full Text] [Related]
29. Topical aldose reductase inhibitor formulations for effective lens drug delivery in a rat model for sugar cataracts.
Kador PF; Randazzo J; Babb T; Koushik K; Takamura Y; Zhu W; Blessing K; Kompella UB
J Ocul Pharmacol Ther; 2007 Apr; 23(2):116-23. PubMed ID: 17444799
[TBL] [Abstract][Full Text] [Related]
30. Ophthalmic solutions: viscosity builders.
Hill RM; Terry JE
Am J Optom Physiol Opt; 1974 Nov; 51(11):847-51. PubMed ID: 4432907
[No Abstract] [Full Text] [Related]
31. Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in albino rabbits.
Lee VH; Robinson JR
J Pharm Sci; 1979 Jun; 68(6):673-84. PubMed ID: 458563
[TBL] [Abstract][Full Text] [Related]
32. Ocular bioavailability and systemic loss of topically applied ophthalmic drugs.
Patton TF; Francoeur M
Am J Ophthalmol; 1978 Feb; 85(2):225-9. PubMed ID: 623195
[TBL] [Abstract][Full Text] [Related]
33. [POLYVINYL ALCOHOL AS A PHARMACEUTICAL BASE FOR ANTIBIOTICS IN OPHTHALMOLOGIC PRACTICE].
MAICHUK IuF
Oftalmol Zh; 1964; 19():350-4. PubMed ID: 14205202
[No Abstract] [Full Text] [Related]
34. An ocular bioavailability comparison in rabbits of prednisolone acetate after repeated topical applications formulated as a high-viscosity gel and as an aqueous suspension.
Johansen S; Rask-Pedersen E; Prause JU
Acta Ophthalmol Scand; 1996 Jun; 74(3):259-64. PubMed ID: 8828723
[TBL] [Abstract][Full Text] [Related]
35. Effect of particle dissolution rate on ocular drug bioavailability.
Hui HW; Robinson JR
J Pharm Sci; 1986 Mar; 75(3):280-7. PubMed ID: 3701612
[TBL] [Abstract][Full Text] [Related]
36. Topically applied aminocaproic acid concentrates in the aqueous humor of the rabbit in therapeutic levels.
Allingham RR; Williams PB; Crouch ER; Loewy DM; Demkowski HC
Arch Ophthalmol; 1987 Oct; 105(10):1421-3. PubMed ID: 3662915
[TBL] [Abstract][Full Text] [Related]
37. Comparison of ophthalmic vehicles using fluorescein uptake technique.
Capella JA; Schaefer IM
Eye Ear Nose Throat Mon; 1974 Jan; 53(1):23-5. PubMed ID: 4208067
[No Abstract] [Full Text] [Related]
38. The assay of benzalkonium chloride in pilocarpine, hypromellose and polyvinyl alcohol ophthalmic drops by second-order derivative ultraviolet spectrophotometry.
Parkin JE
J Pharm Biomed Anal; 1993 Jul; 11(7):609-11. PubMed ID: 8399536
[No Abstract] [Full Text] [Related]
39. Vehicle effects in ophthalmic bioavailability: an evaluation of polymeric inserts containing pilocarpine.
Saettone MF; Giannaccini B; Chetoni P; Galli G; Chiellini E
J Pharm Pharmacol; 1984 Apr; 36(4):229-34. PubMed ID: 6144768
[TBL] [Abstract][Full Text] [Related]
40. General Pharmacokinetic Model for Topically Administered Ocular Drug Dosage Forms.
Deng F; Ranta VP; Kidron H; Urtti A
Pharm Res; 2016 Nov; 33(11):2680-90. PubMed ID: 27431864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
